172 related articles for article (PubMed ID: 31719571)
1. Effect of High-dose Antithrombin Supplementation in Patients with Septic Shock and Disseminated Intravascular Coagulation.
Kim YJ; Ko BS; Park SY; Oh DK; Hong SB; Jang S; Kim WY
Sci Rep; 2019 Nov; 9(1):16626. PubMed ID: 31719571
[TBL] [Abstract][Full Text] [Related]
2. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
Iba T; Saitoh D; Wada H; Asakura H
Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
[TBL] [Abstract][Full Text] [Related]
7. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
Nagafuchi H; Eguchi Y; Ikeda T
Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
[TBL] [Abstract][Full Text] [Related]
8. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
Lee S; Kim J; Ji M; Moon H; Lee W
Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
[TBL] [Abstract][Full Text] [Related]
11. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
Cohendy R; Lefrant JY; de la Coussaye JE
Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
[No Abstract] [Full Text] [Related]
12. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
Kuroda H; Tatsumi H; Sonoda T; Masuda Y
Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey.
Iba T; Saito D; Wada H; Asakura H
Thromb Res; 2012 Sep; 130(3):e129-33. PubMed ID: 22542365
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
15. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.
Iizuka Y; Sanui M; Sasabuchi Y; Lefor AK; Hayakawa M; Saito S; Uchino S; Yamakawa K; Kudo D; Takimoto K; Mayumi T; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
Crit Care; 2017 Jul; 21(1):181. PubMed ID: 28701223
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
17. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation.
Umegaki T; Kunisawa S; Nishimoto K; Kamibayashi T; Imanaka Y
Sci Rep; 2020 Mar; 10(1):4874. PubMed ID: 32184456
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]